Risk of recurrence following delayed large flap reconstruction after mastectomy for breast cancer
Anne Elisabeth Isern(Lund University), Anita Ringberg(Uppsala University), Janne Malina(Lund University), Thomas Mårtensson(Lund University), Anna M. Bofin(Norwegian University of Science and Technology), Göran Landberg(Sahlgrenska University Hospital), I. Tengrup(Skåne University Hospital), Niklas Loman(Lund University), Anne Irene Hagen(Norwegian University of Science and Technology), Jonas Manjer(Lund University)
Cited by 38
Related Papers
Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 Studies
|The American Journal of Human Genetics|2003|3.7k
Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial
|The Lancet|2010|2.3k
Olaparib Monotherapy in Patients With Advanced Cancer and a Germline <i>BRCA1/2</i> Mutation
|Journal of Clinical Oncology|2014|1.7k
Obesity, metabolic factors and risk of different histological types of lung cancer: A Mendelian randomization study
|PLoS ONE|2017|668
An HIF-1α/VEGF-A Axis in Cytotoxic T Cells Regulates Tumor Progression
|Cancer Cell|2017|534